Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know 2016 is a course that covers topics such as:
- Systematic reviews and meta-analysis
- Key principles and practiceIdentification of HTA (Health Technology Assessment) reports
- Economic evaluation
- Clinical evaluation
- Quality assessment
- Critical appraisal
- Value proposition development
- Context-specific application
- HTA from different perspectives (decision makers, industry, etc.)
Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know 2016 brings together attendees from:
- The pharmaceutical industry working in the field of Drug Development, Market Access, Marketing, Regulatory Affairs and Medical Affairs
- Government agencies, payer organisations and medical insurance companies
- Hospital managers, academia and non-profit organisations